| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT01816256 |
| P767 | contributor to the creative work or subject | Novartis | Q507154 |
| P17 | country | Canada | Q16 |
| P582 | end time | 2019-03-11 | |
| P1050 | medical condition | arterial hypertension | Q41861 |
| thrombosis | Q261327 | ||
| polycythemia | Q933716 | ||
| polycythemia vera | Q948318 | ||
| chronic idiopathic myelofibrosis | Q3857106 | ||
| P1132 | number of participants | 102 | |
| P580 | start time | 2013-05-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms |
Search more.